Table 3.
Testosterone levels
| Change from Baseline | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| n | Mean | SD | Median | IQR | Base Mean | n | Mean | SD | |
| Ultrasensitive Assay Testosterone, ng/dL | |||||||||
| Baseline* | 116 | 10.308 | 11.4926 | 8.200 | 6.190 | ||||
| Cycle 4, Day 1 | 92 | 0.387 | 0.4397 | 0.260 | 0.280 | 10.640 | 87 | −10.240 | 12.4870 |
| Cycle 7, Day 1 | 87 | 0.378 | 0.2840 | 0.290 | 0.340 | 10.560 | 83 | −10.174 | 12.9588 |
*
One patient had a screening testosterone level of 6.78 ng/dL, meeting entry criteria, but reported 117.38 ng/dL at Cycle 1, Day 1. On Cycle 4, Day 1, the patient’s testosterone was 3.15 ng/dL and on Cycle 7, Day 1 the patient’s testosterone level was 0.59 ng/dL.